Overview
When building a clinical decision support system capable of diagnosing the world’s rarest and most complex genetic conditions, the foundational dataset must be absolutely unassailable. An artificial intelligence algorithm is only as intelligent as the underlying truth data it relies upon. If the foundational database is plagued by inaccuracies, outdated clinical descriptions, or unverified public submissions, the resulting AI outputs will be inherently flawed and clinically dangerous. For this reason, Sanjeevni chose to integrate deeply and exclusively with Orphanet as our primary rare disease knowledge graph. Established in 1997 in France and now supported by a massive international consortium of scientific and medical organizations across 40 countries, Orphanet is universally recognized as the definitive global reference portal for information on rare diseases and orphan drugs. It is not a crowdsourced wiki; it is a meticulously curated database maintained by an elite network of dedicated medical professionals, geneticists, and researchers. Every single disease profile added to the Orphanet registry undergoes rigorous peer review to ensure that the clinical descriptions, genetic linkages, and epidemiological data reflect the absolute cutting edge of established medical science. By embedding the entire Orphanet nomenclature (specifically the ORPHA code system) into the core architecture of the Sanjeevni platform, we instantly equip every physician using our software with the collective rare disease knowledge of the entire global medical community. When a clinician uploads a complex patient case into Sanjeevni, they are not relying on a black-box AI guessing game; they are executing a mathematically precise query against the most respected, rigorously validated rare disease database in existence.
The Global Authority on Rare Diseases
When building a clinical decision support system capable of diagnosing the world’s rarest and most complex genetic conditions, the foundational dataset must be absolutely unassailable. An artificial intelligence algorithm is only as intelligent as the underlying truth data it relies upon. If the foundational database is plagued by inaccuracies, outdated clinical descriptions, or unverified public submissions, the resulting AI outputs will be inherently flawed and clinically dangerous. For this reason, Sanjeevni chose to integrate deeply and exclusively with Orphanet as our primary rare disease knowledge graph.
Comprehensive Disease Profiling and Prevalence Data
The depth of information provided by our Orphanet integration is what allows Sanjeevni’s Bayesian algorithms to achieve such high degrees of diagnostic accuracy. Orphanet currently tracks over 11,000 distinct clinical entities. For each of these thousands of rare diseases, Orphanet provides a comprehensive profile that extends far beyond a simple text description. Crucially for our algorithmic models, each disease in the Orphanet database is explicitly mapped to the precise Human Phenotype Ontology (HPO) terms that characterize its clinical presentation.
Continuous Synchronization and Evolving Knowledge
The field of medical genetics is expanding at an exponential rate. New syndromes are discovered, previously unconnected phenotypes are linked to known diseases, and epidemiological prevalence statistics are constantly refined as global diagnostic capabilities improve. A static database in this rapidly evolving scientific environment becomes clinically obsolete in a matter of months. To ensure the Sanjeevni platform remains a state-of-the-art diagnostic tool, our engineering infrastructure maintains a continuous, automated synchronization pipeline with Orphanet’s primary servers.